Andrey Doronichev’s Post

Congrats Kong T. Nguyen! Proud to welcome you as the new VP of Drug Discovery at OPTIC!

I regularly find myself feeling dumb. That's because I'm surrounded by incredibly smart people. This is a conscious choice. I'd argue, being the dumbest person in the room is an underrated privilege. It's uncomfortable, but it's incredibly beneficial. Conversely, if you're always the smartest person in the room, it might mean you're in the wrong room. I grew up on a poor neighborhood of post-USSR Moscow in the 90s, an environment where I often was smarter than those around me. However, they were mostly stronger and meaner. So whenever I heard the phrase, "Oh, so you think you're smart?" it usually meant I was about to get my ass kicked. My perspective shifted when I transferred into a STEM school in the 8th grade. There, I discovered what it was like to not understand my peers for a good reason — not because I could not speak the prison slang, but because I hadn't read enough books. It was a priceless experience. Since then, seeking out the "smartest room" has become a life strategy. That's why I worked night shifts at a local ISP tech support call center since high school. For the same reason, I left my first profitable but simple business to join Google. And that's why now, I'm excited to be building at the intersection of AI and Life-sciences, even though I'm struggling to keep up with my team on the knowledge of biochemistry. Being in an environment where you're the smartest but not in a position of power teaches you to keep your mouth shut. If you're in power as well, being the smartest can lead to laziness and dull your sharpness. However, if everyone around you is smarter, there's only one thing left to do: relax your ego and embrace growth.

Congrats Dmitry Vysotski 🔜GDC

Exciting news! We have been invited to attend our first JPM Healthcare Conference, and we couldn't be more thrilled to connect with pharma companies interested in research partnerships with Bioptic. Bioptic.io is like "Google for molecules" - our generative AI engine scans trillions of compounds to identify novel drug candidates that are similar by activity, but might have completely different structures. It takes you to the parts of chemical space that you'd never go to otherwise. If you're attending the conference and want to meet up, please don't hesitate to reach out. We'd love to connect! #JPMHealthcareConference #Bioptic #AIinPharma #DrugDiscovery #ai

I worked at Google for 13 years. I resigned in 2021 and moved on to explore life further. Here's what happened next... For half a year, I just rested. Rode my bike, wrote a blog, recorded music. At some point I started to miss working with smart people, and founded OPTIC. I was lucky enough to find great co-founders, investors, and a team. We got into AI research at the intersection of industries. Our first product — Optic.xyz, a detector of fake digital art, based on our proprietary Similarity Search technology, was at the intersection of AI and Web3.. It became a market leader within a year and generated several million dollars in revenue. But the NFT market crashed, and we decided to exit. We sold this asset to Yakoa and moved on. Our second product, AIorNot.com — a detector of AI-generated media, we launched right before the whirlwind of fakes like "Pope in Balenciaga." The service took off immediately and got featured in top media outlets and saw amazing organic growth. In September, we spun it off into a separate company AI or Not. Meanwhile, my co-founders and I moved on again to explore the intersection of AI and Bio. This time applying our Similarity Search technology for small molecule drug discovery: http://www.bioptic.io We believe that soon neural networks will be able to generate not only pictures and texts but also formulas for new cancer drugs. It's insanely interesting! These days, I'm taking classes in chemistry and biology, going to scientific congresses, hanging out with scientists in labs, and thanking the universe for the new opportunity to explore life. This time literally: to research Life as a scientific phenomenon.

Excited to announce a significant milestone: after seeing a tremendous growth of AIorNOT.com, we officially spun it off into a new, independent company: AI or Not, now led by a fantastic new CEO, Anatoly Kvitnitsky. Anatoly brings unique expertise of leading Growth at Trulioo. Combined with the world-class AI research team joining him from OPTIC, I'm sure the new venture is poised to make a substantial impact in defending digital authenticity in the age of generative AI. As OPTIC shifts its focus to revolutionizing drug discovery with AI (bioptic.io), we're confident in AI or Not's ability to continue our legacy of excellence and innovation. More in our recent press release: https://lnkd.in/gu6JdgCt

Two exciting news about aiornot.com by OPTIC First, we’ve just launched AI-generated audio detection - both music and voice: try it at aiornot.com/audio Second, we are featured in the latest episode of Future of Everything podcast by The Wall Street Journal: https://lnkd.in/gpH4r4UH

Wanna know what your competitors are doing well and not so well? Try Essense.io Competitor Analysis feature. Our AI reads thousands of customer reviews on your competitors and generates a detailed, actionable report for you in minutes.